USE OF SOYBEAN BROAD-SPECTRUM DISEASE RESISTANCE RELATED GENE
20220243218 · 2022-08-04
Inventors
- Xianzhong Feng (Changchun, Jilin, CN)
- Suxin Yang (Changchun, Jilin, CN)
- Dongmei Wang (Changchun, Jilin, CN)
- Hui Yu (Changchun, Jilin, CN)
Cpc classification
C12N15/8213
CHEMISTRY; METALLURGY
International classification
Abstract
The GmLMM1 gene, which is involved in the regulation of PTI immune responses, Phytophthora resistance, bacterial blight of soybean disease, soybean halo disease, etc., is cloned in soybeans. The PTI immune response and pathogen resistance of plants can be negatively regulated via the GmLMM1 gene. By reducing the expression of GmLMM1, the PTI immune response of plants can be effectively enhanced, and the pathogen resistance of plants can be increased. Cloning and functional discovery of the GmLMM1 gene provide important foundations and theoretical support for research on the related mechanisms of soybean disease resistance and provide valuable genetic resources for advancing the research and application of plant defense systems. Additionally, cloning and functional delivery of the GmLMM1 gene allows for breeding new soybean varieties with high disease resistance.
Claims
1. (canceled)
2. A method for enhancing the PTI immune response of plants, the method comprising: reducing the expression of a GmLMM1 gene or a mutant GmLMM1 gene or a protein encoded by the GmLMM1 gene or the mutant GmLMM1 gene.
3. (canceled)
4. A method for plant genetic breeding or transgenic plant preparation, the method comprising: regulating the expression of a soybean GmLMM1 gene or a mutant soybean GmLMM1 gene or a protein encoded by the soybean GmLMM1 gene or the mutant soybean GmLMM1 gene.
5. The method according to claim 2, wherein the protein encoded by the soybean GmLMM1 gene comprises any one of the following amino acid sequences: (1) an amino acid sequence represented by SEQ ID NO. 1; (2) an amino acid sequence obtained by substitution, insertion or deletion of one or more amino acids in the amino acid sequence represented by SEQ ID NO. 1, and having the same function as the amino acid sequence represented by SEQ ID NO. 1; or (3) an amino acid sequence comprising at least 80% homology to the amino acid sequence represented by SEQ ID NO. 1; the protein encoded by the mutant gene of the soybean GmLMM1 gene has any one of the following amino acid sequences: (1) an amino acid sequence represented by SEQ ID NO. 3; (2) an amino acid sequence obtained by substitution, insertion or deletion of one or more amino acids in the amino acid sequence represented by SEQ ID NO. 3, and having the same function as the amino acid sequence represented by SEQ ID NO. 3; and (3) an amino acid sequence having at least 80% homology to the amino acid sequence represented by SEQ ID NO. 3.
6. The method according to claim 2, further comprising increasing a soybean pathogen resistance by reducing the expression of the GmLMM1 gene via targeted knockout of the GmLMM1 gene using CRISPR/Cas9 technology.
7. The method according to claim 6, wherein the gRNA comprises a nucleotide sequence represented by SEQ ID NO. 5.
8. A method for regulating a pathogen resistance of plants, the method comprising: regulating the expression of GmLMM1 gene or a mutant GmLMM1 gene or a protein encoded by the soybean GmLMM1 gene or a mutant GmLMM1 gene in plants, wherein the protein encoded by the soybean GmLMM1 gene comprises any one of the following amino acid sequences: (1) an amino acid sequence represented by SEQ ID NO. 1; (2) an amino acid sequence obtained by substitution, insertion or deletion of one or more amino acids in the amino acid sequence represented by SEQ ID NO. 1, and having the same function as the amino acid sequence represented by SEQ ID NO. 1; or (3) an amino acid sequence comprising at least 80% homology to the amino acid sequence represented by SEQ ID NO. 1; and wherein the protein encoded by the mutant GmLMM1 gene of the soybean GmLMM1 gene comprises any one of the following amino acid sequences: (1) an amino acid sequence represented by SEQ ID NO. 3; (2) an amino acid sequence obtained by substitution, insertion or deletion of one or more amino acids in the amino acid sequence represented by SEQ ID NO. 3, and having the same function as the amino acid sequence represented by SEQ ID NO. 3; or (3) an amino acid sequence comprising at least 80% homology to the amino acid sequence represented by SEQ ID NO. 3.
9. The method according to claim 8, wherein the pathogen resistance of plants is increased by reducing the expression of the GmLMM1 gene or the protein encoded by the GmLMM1 gene in the plants.
10. The method according to claim 8, wherein the pathogen resistance is increased by reducing the expression of the GmLMM1 gene via targeted knockout of the soybean GmLMM1 gene, wherein targeted knockout comprises using CRISPR/Cas9 technology.
11. The method according to claim 2, wherein reducing the expression of the expression of a GmLMM1 gene or a mutant GmLMM1 gene or a protein encoded by the GmLMM1 gene or the mutant GmLMM1 gene comprises reducing the expression of a protein encoded by the GmLMM1 gene, wherein the protein encoded by the GmLMM1 gene comprises any one of the following amino acid sequences: (1) an amino acid sequence represented by SEQ ID NO. 1; (2) an amino acid sequence obtained by substitution, insertion or deletion of one or more amino acids in the amino acid sequence represented by SEQ ID NO. 1, and having the same function as the amino acid sequence represented by SEQ ID NO. 1; or (3) an amino acid sequence comprising at least 80% homology to the amino acid sequence represented by SEQ ID NO. 1.
12. The method according to claim 11, wherein reducing the expression of a protein encoded by the GmLMM1 gene or the mutant GmLMM1 gene comprises reducing the expression of a protein encoded by the GmLMM1 gene, wherein the protein encoded by the GmLMM1 gene comprises an amino acid sequence comprising at least 90% homology to the amino acid sequence represented by SEQ ID NO. 1.
13. The method according to claim 12, wherein reducing the expression of a protein encoded by the GmLMM1 gene or the mutant GmLMM1 gene comprises reducing the expression of a protein encoded by the GmLMM1 gene, wherein the protein encoded by the GmLMM1 gene comprises an amino acid sequence comprising 95% homology to the amino acid sequence represented by SEQ ID NO. 1.
14. The method according to claim 2, wherein reducing the expression of the expression of a GmLMM1 gene or a mutant GmLMM1 gene or a protein encoded by the GmLMM1 gene or the mutant GmLMM1 gene comprises reducing the expression of a protein encoded by the mutant GmLMM1 gene, wherein the protein encoded by the mutant GmLMM1 gene comprises any one of the following amino acid sequences: (1) an amino acid sequence represented by SEQ ID NO. 3; (2) an amino acid sequence obtained by substitution, insertion or deletion of one or more amino acids in the amino acid sequence represented by SEQ ID NO. 3, and having the same function as the amino acid sequence represented by SEQ ID NO. 3; or (3) an amino acid sequence comprising at least 80% homology to the amino acid sequence represented by SEQ ID NO. 3.
15. The method according to claim 14, wherein reducing the expression of the expression of a GmLMM1 gene or a mutant GmLMM1 gene or a protein encoded by the GmLMM1 gene or the mutant GmLMM1 gene comprises reducing the expression of a protein encoded by the mutant GmLMM1 gene, wherein the protein encoded by the mutant GmLMM1 gene comprises an amino acid sequence comprising at least 90% homology to the amino acid sequence represented by SEQ ID NO. 3.
16. The method according to claim 15, wherein reducing the expression of the expression of a GmLMM1 gene or a mutant GmLMM1 gene or a protein encoded by the GmLMM1 gene or the mutant GmLMM1 gene comprises reducing the expression of a protein encoded by the mutant GmLMM1 gene, wherein the protein encoded by the mutant GmLMM1 gene comprises an amino acid sequence comprising 95% homology to the amino acid sequence represented by SEQ ID NO. 3.
17. The method according to claim 5, wherein the protein encoded by the soybean GmLMM1 gene comprises an amino acid sequence comprising at least 90% homology to the amino acid sequence represented by SEQ ID NO. 1.
18. The method according to claim 5, the protein encoded by the mutant gene of the soybean GmLMM1 gene comprises an amino acid sequence having at least 90% homology to the amino acid sequence represented by SEQ ID NO. 3.
19. The method according to claim 8, wherein regulating the expression of GmLMM1 gene or a mutant GmLMM1 gene or a protein encoded by the soybean GmLMM1 gene or a mutant GmLMM1 gene in plants comprises regulating the expression of the protein encoded by the soybean GmLMM1 gene, wherein the protein encoded by the soybean GmLMM1 gene comprises an amino acid sequence comprising at least 90% homology to the amino acid sequence represented by SEQ ID NO. 1.
20. The method according to claim 8, wherein regulating the expression of GmLMM1 gene or a mutant GmLMM1 gene or a protein encoded by the soybean GmLMM1 gene or a mutant GmLMM1 gene in plants comprises regulating the expression of the protein encoded by the mutant gene of the soybean GmLMM1 gene, wherein the protein encoded by the mutant GmLMM1 gene of the soybean GmLMM1 gene comprises an amino acid sequence comprising at least 90% homology to the amino acid sequence represented by SEQ ID NO. 3.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0050]
[0051]
[0052]
[0053]
[0054]
[0055]
DETAILED DESCRIPTION
[0056] The preferred embodiments of the present disclosure will be described in detail below in conjunction with Examples. It should be understood that the following Examples are given for illustrative purposes only, and are not intended to limit the scope of the present disclosure. A person skilled in the art can make various modifications and substitutions to the present disclosure without departing from the purpose and spirit of the present disclosure.
[0057] The experimental methods used in the following Examples are conventional methods unless otherwise specified.
[0058] The materials and reagents used in the following Examples can be obtained from commercial sources unless otherwise specified.
Example 1: Identification of Phytophthora Resistance Phenotype of GmLMM1 Mutant to Phytophthora
[0059] The mutant GmLMM1 was obtained by screening the mutant library obtained by performing EMS mutagenesis on Williams 82. Phytophthora sojae (P. sojae) P7076 hyphae blocks were used to inoculate leaves of wild-type “Williams 82” and leaves of GmLMM1 mutant. After 48 hours of infection, pathogen infected leaves were observed under ultraviolet light (
Example 2: Significantly Enhanced Pathogen Resistance in the Transgenic Plants with GmLMM1 Gene Knocked Out
[0060] A CRISPR/Cas9 recombinant plasmid with gRNA (sequence as represented by SEQ ID NO. 5) driven by GmU6 promoter and Cas9 protein driven by GmUbi3 promoter was constructed, and the recombinant plasmid was introduced into the wild-type soybean variety Dongnong 50 (DN50) with an Agrobacterium-mediated genetic transformation system. After genetic transformation, Ti generation transgenic plants were finally obtained. Phytophthora sojae (P. sojae) P7076 hyphae blocks were used to inoculate leaves of wild-type DN50 and leaves of transgenic plant CRISPR with GmLMM1 gene knocked out. After 60 hours of infection, trypan blue staining was used to observe the difference in infection, and the statistics of the area of lesion formation was performed (
Example 3: Inhibition of PTI Immune Response of Plants by GmLMM1 Gene
[0061] Agrobacterium was injected into tobaccos to transiently express GFP (control group) and GmLMM1 (experimental group), and after 24 hours, water and flg22 (a small peptide containing 22 amino acids from conserved N-terminus of flagellin and commonly used in plant immunity research) were used for treatment, respectively. The active oxygen burst was detected after treatment, and it was found that transient overexpression of GmLMM1 can inhibit the active oxygen burst induced by flg22 (
[0062] Although the present disclosure has been described in detail with general descriptions, specific embodiments and tests above, it is obvious to a person skilled in the art that some modifications or improvements can be made on the basis of the present disclosure. Therefore, all these modifications or improvements made without departing from the spirit of the present disclosure belong to the scope of the present disclosure.
INDUSTRIAL APPLICABILITY
[0063] The present disclosure provides the use of a soybean broad-spectrum disease resistance related gene GmLMM1. In the present disclosure, the GmLMM1 gene, which is involved in the regulation of PTI immune response, Phytophthora resistance, bacterial blight of soybeans disease, halo blight of the common bean, Phaseolus vulgaris, etc., is cloned in soybeans. The PTI immune response and pathogen resistance of plants can be negatively regulated by the GmLMM1 gene; and by reducing the expression of the GmLMM1 gene, the PTI immune response of plants can be effectively enhanced, and the pathogen resistance of plants can be increased. The cloning and functional discovery of the GmLMM1 gene provide important gene foundations and theoretical support for research on the related mechanisms of soybean disease resistance, and provide valuable gene resources for advancing the research and application of plant defense systems and for breeding new soybean varieties with high disease resistance, and thus have an important application value and prospects in the genetic engineering-based breeding of soybean disease resistance.